Baby Safety / Compounds / Buprenorphine

Is Buprenorphine safe for babies and kids?

Very high risk for kids

Infants are more vulnerable to Buprenorphine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is buprenorphine?

The IUPAC name is (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol.

Also known as: (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol, Temgesic, Buprenophine, Buprenorfina.

IUPAC name
(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol
CAS number
52485-79-7
Molecular formula
C29H41NO4
Molecular weight
467.6 g/mol
SMILES
CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
PubChem CID
644073

Risk for babies

Very high risk

Infants are more vulnerable to Buprenorphine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Buprenorphine, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

2 regulatory and scientific bodies have classified Buprenorphine. The classifications differ — that's the data.

AgencyYearClassificationNotes
FDA—Approved for opioid use disorder (OUD) treatmentAvailable as Suboxone (buprenorphine/naloxone sublingual), Sublocade (monthly injectable), and Probuphine (subdermal implant)
FDA—Approved for pain treatmentAvailable as Belbuca (buccal film), Butrans (transdermal patch), and Brixtra (injection)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter buprenorphine

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Buprenorphine:

  • Therapeutic alternatives (consult prescriber)
    Trade-offs: Drug-specific. Cannot substitute without medical guidance.
    Relative cost: 1.2-2×

Frequently asked questions

Is buprenorphine safe for kids?

Infants are more vulnerable to Buprenorphine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What products contain buprenorphine?

Buprenorphine appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to buprenorphine?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See Buprenorphine in the baby app

Look up products containing buprenorphine, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (2)
  1. US FDA: Buprenorphine — OUD Treatment Approvals (Suboxone, Sublocade, Probuphine), Ceiling Effect on Respiratory Depression, Naloxone Abuse Deterrent Component, Pediatric Exposure Risk, Feline Analgesic Use, and Pregnancy/NOWS Outcomes (2022) (2022) — regulatory
  2. SAMHSA: Clinical Practice Guideline for the Treatment of Opioid Use Disorder — Buprenorphine Prescribing, Precipitated Withdrawal Management, Child Exposure Prevention (Suboxone film child-resistant packaging), and Comparison with Methadone (2023) (2023) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →